⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CBIO News
Crescent Biopharma, Inc. Common Stock
Continuity Biosciences und Breakthrough T1D arbeiten zusammen, um die NICHE®-Zelltherapie-Plattform auf dem Weg zur First-in-Human-Studie voranzubringen USA - Deutsch Middle East - English USA - English Korea - 한국어
prnewswire.com
CBIO
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study USA - English Middle East - English
prnewswire.com
CBIO
Cellipont Bioservices and BobcatBio Announce Strategic Collaboration to Advance Macrophage Cell Therapy for Solid Tumors
prnewswire.com
CBIO
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Form 8-K
sec.gov
CBIO
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
globenewswire.com
CBIO
Crescent Biopharma to Present at March Investor Conferences
globenewswire.com
CBIO
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
globenewswire.com
CBIO
Vibrant Capital Launches to Scale AI in the Real Economy
prnewswire.com
CBIO